TP53 mutations in human cancers: origins, consequences, and clinical use.

Olivier, M., Hollstein, M., Hainaut, P.·2010·Cold Spring Harbor Perspectives in Biology

DOI 10.1101/cshperspect.a001008

Cited by (1,002)

Items 301–400 of 1,002

A phase I study of the HDM2 antagonist SAR405838 combined with the MEK inhibitor pimasertib in patients with advanced solid tumours
de Weger, Vincent A., de Jonge, Maja, Langenberg, Marlies H. G., Schellens, Jan H. M., Lolkema, Martijn, Varga, Andrea, Demers, Brigitte, Thomas, Koruth, Hsu, Karl, Tuffal, Gilles et al. · 2019 · British Journal of Cancer
Revolutionizing the landscape of colorectal cancer treatment: The potential role of immune checkpoint inhibitors
Mai Fathy Tolba · 2020 · International Journal of Cancer
Outcomes in patients with newly diagnosed TP53‐mutated acute myeloid leukemia with or without venetoclax‐based therapy
Sangeetha Venugopal, Mahran Shoukier, Marina Y Konopleva, Courtney Denton Dinardo, Farhad Ravandi, Nicholas James Short, Michael Andreeff, Gautam M. Borthakur, Naval Guastad Daver, Naveen Pemmaraju et al. · 2021 · Cancer
Metabolic Health, Mitochondrial Fitness, Physical Activity, and Cancer
Vicente Javier Clemente‐Suárez, Alexandra Martín-Rodríguez, Laura Redondo-Flórez, Pablo Ruisoto, Eduardo Navarro-Jiménez, Domingo Jesús Ramos‐Campo, José Francisco Tornero-Aguilera · 2023 · Cancers
Subtelomeric p53 binding prevents accumulation of DNA damage at human telomeres
Stephen Tutton, Greggory A Azzam, Nicholas Stong, Olga V. Vladimirova, Andreas Wiedmer, Jessica Monteith, Kate Beishline, Zhuo Wang, Zhong Deng, Harold C. Riethman et al. · 2015 · The EMBO Journal
Integrative genome analysis of somatic p53 mutant osteosarcomas identifies Ets2-dependent regulation of small nucleolar RNAs by mutant p53 protein
Rasoul Pourebrahim, Yun Zhang, Bin Liu, Ruli Gao, Shunbin Xiong, Patrick P. Lin, Mark J. McArthur, Michael C. Ostrowski, Guillermina Lozano · 2017 · Genes & Development
Podocalyxin in Normal Tissue and Epithelial Cancer
Ngoc Le Tran, Yao Wang, Guiying Nie · 2021 · Cancers
Targeting Acute Myeloid Leukemia with Venetoclax; Biomarkers for Sensitivity and Rationale for Venetoclax-Based Combination Therapies
Mila S Griffioen, D. D. de Leeuw, Jeroen Janssen, L. Smit · 2022 · Cancers
Ferroptosis: a new hunter of hepatocellular carcinoma
Yulang Jiang, Yongxin Yu, Ziyang Pan, Christian Glandorff, Mingyu Sun · 2024 · Cell Death Discovery
Targeting mutant p53: a key player in breast cancer pathogenesis and beyond
Hina Qayoom, Burhan Ul Haq, Shazia Sofi, Nusrat Jan, Asma Jan, Manzoor Ahmad Mir · 2024 · Cell Communication and Signaling
Crocetin exploits p53-induced death domain (PIDD) and FAS-associated death domain (FADD) proteins to induce apoptosis in colorectal cancer
Pallab Ray, Deblina Guha, Juni Chakraborty, Shuvomoy Banerjee, Arghya Adhikary, Samik Chakraborty, Tanya Das, Gaurisankar Sa · 2016 · Scientific Reports
Developing DNA methylation-based diagnostic biomarkers
Hye-Rim Kim, Xudong Wang, Peng Jin · 2018 · Journal of genetics and genomics/Journal of Genetics and Genomics
Spontaneous and inherited TP53 genetic alterations
Arnold J. Levine · 2021 · Oncogene
LRH-1 drives colon cancer cell growth by repressing the expression of theCDKN1Agene in a p53-dependent manner
Holly B Kramer, Chun‐Fui Lai, Hetal Patel, Manikandan Periyasamy, Meng‐Lay Lin, Stephan M. Feller, Frances V. Fuller-Pace, David W. Meek, Simak Ali, Laki Buluwela · 2015 · Nucleic Acids Research
TP53 Gain-of-Function and Non–Gain-of-Function Mutations Are Differentially Associated With Sidedness-Dependent Prognosis in Metastatic Colorectal Cancer
Minggui Pan, Chen Jiang, Pam Tse, Ninah Achacoso, Stacey Alexeeff, Aleyda V. Solorzano, Elaine Chung, Wenwei Hu, Thach-Giao Truong, Amit Arora et al. · 2021 · Journal of Clinical Oncology
TP53 Mutation-Mediated Immune Evasion in Cancer: Mechanisms and Therapeutic Implications
Chuqi Wang, Jordan Yong Ming Tan, Nishtha Chitkara, Shruti Bhatt · 2024 · Cancers
FBP1 controls liver cancer evolution from senescent MASH hepatocytes
Li Gu, Yahui Zhu, Shuvro Prokash Nandi, Maiya Lee, Kosuke Watari, Breanna Bareng, Masafumi Ohira, Yuxiao Liu, Sadatsugu Sakane, Rodrigo Carlessi et al. · 2025 · Nature
Mdm2 Is Required for Survival and Growth of p53-Deficient Cancer Cells
Kyle P. Feeley, Clare M. Adams, Ramkrishna Mitra, Christine M. Eischen · 2017 · Cancer Research
TRIM proteins in lung cancer: Mechanisms, biomarkers and therapeutic targets
Weihua Zhan, Song Zhang · 2021 · Life Sciences
Global Developmental Gene Programing Involves a Nuclear Form of Fibroblast Growth Factor Receptor-1 (FGFR1)
Christopher J. Terranova, Sridhar Tatarao Narla, Yu-Wei Lee, Jonathan Bard, Abhirath Parikh, Ewa K. Stachowiak, Emmanuel S. Tzanakakis, Michael Joseph Buck, Barbara G. Birkaya, Michal K. Stachowiak · 2015 · PLoS ONE
Combining Ramachandran plot and molecular dynamics simulation for structural-based variant classification: Using TP53 variants as model
Benjamin Tam, Siddharth Sinha, San Ming Wang · 2020 · Computational and Structural Biotechnology Journal
AGR2 oncoprotein inhibits p38 MAPK and p53 activation through a DUSP10‐mediated regulatory pathway
Roman Hrstka, Pavla Bouchalová, Eva Michalová, Eva Matoulková, Petr Müller, Philip John Coates, Bořivoj Vojtěšek · 2015 · Molecular Oncology
Mutant p53 promotes ovarian cancer cell adhesion to mesothelial cells via integrin β4 and Akt signals
Jong-Gyu Lee, Ji‐Hye Ahn, Tae Jin Kim, Jae Ho Lee, Jung‐Hye Choi · 2015 · Scientific Reports
Role of TP53 Mutations in Vulvar Carcinomas
Matthias Choschzick, Widianto Hantaredja, Pierre Tennstedt, Frederike Gieseking, Linn Lena Woelber, Ronald Simon · 2011 · International Journal of Gynecological Pathology
Characterization of background noise in capture-based targeted sequencing data
Gahee Park, Joo Kyung Park, Seung‐Ho Shin, Hyo-Jeong Jeon, Nayoung K. D. Kim, Yeon Jeong Kim, Hyun‐Tae Shin, Eunjin Lee, Kwang Hyuck Lee, Dae‐Soon Son et al. · 2017 · Genome biology
Restoring the p53 ‘Guardian’ Phenotype in p53-Deficient Tumor Cells with CRISPR/Cas9
Chira, Sergiu, Gulei, Diana, Hajitou, Amin, Berindan-Neagoe, Ioana · 2018 · Trends in Biotechnology
Glucose-induced CRL4COP1-p53 axis amplifies glycometabolism to drive tumorigenesis
Yang Su, Yifan Luo, Peitao Zhang, Hong Lin, Weijie Pu, Hongyun Zhang, Huifang Wang, Yi Hao, Yihang Xiao, Xiaozhe Zhang et al. · 2023 · Molecular Cell
Nanoreceptors promote mutant p53 protein degradation by mimicking selective autophagy receptors
Xiaowan Huang, Ziyang Cao, Jieying Qian, Tao Ding, Yanxia Wu, Hao Zhang, Suqin Zhong, Xiaoli Wang, Xiaoguang Ren, Wang Zhang et al. · 2024 · Nature Nanotechnology
Nitidine chloride induces apoptosis in human hepatocellular carcinoma cells through a pathway involving p53, p21, Bax and Bcl-2
Xianhong Ou, Yunhua Lu, Liu-Feng Liao, Danni Li, Limin Liu, Huagang Liu, Heng Xu · 2014 · Oncology Reports
Interplay between Mitochondrial Metabolism and Cellular Redox State Dictates Cancer Cell Survival
Brittney Joy-Anne Foo, Jie Qing Eu, Jayshree L. Hirpara, Shazib Pervaiz · 2021 · Oxidative Medicine and Cellular Longevity
Pan-cancer prognostic genetic mutations and clinicopathological factors associated with survival outcomes: a systematic review
Jurgita Gammall, Alvina Grace Lai · 2022 · npj Precision Oncology
Oncogenic activation of ERG: A predominant mechanism in prostate cancer
Shiv Srivastava, Taduru Sreenath, Albert Dobi, György Petrovics · 2011 · Journal of Carcinogenesis
Saikosaponin-d, a calcium mobilizing agent, sensitizes chemoresistant ovarian cancer cells to cisplatin-induced apoptosis by facilitating mitochondrial fission and G2/M arrest
Hideaki Tsuyoshi, Vincent Kam Wai Wong, Yu Kyeong Han, Makoto Orisaka, Yoshio Yoshida, Benjamin K. Tsang · 2017 · Oncotarget
Structural and sequential context of p53: A review of experimental and theoretical evidence
Taniya Saha, Rajiv K. Kar, Gaurisankar Sa · 2014 · Progress in Biophysics and Molecular Biology
Reversed-phase ion-pair liquid chromatography electrospray ionization tandem mass spectrometry for separation, sequencing and mapping of sites of base modification of isomeric oligonucleotide adducts using monolithic column
Vaneet Kumar Sharma, James J. Glick, Paul Vouros · 2012 · Journal of Chromatography A
Activation of PTHrP-cAMP-CREB1 signaling following p53 loss is essential for osteosarcoma initiation and maintenance
Mannu Walia, Patricia MW Ho, Scott Taylor, Alvin JM Ng, Ankita Gupte, Alistair Morgan Chalk, Andrew C.W. Zannettino, Thomas John Martin, Carl R. Walkley · 2016 · eLife
Prognostic and histogenetic roles of gene alteration and the expression of key potentially actionable targets in salivary duct carcinomas
Tomotaka Shimura, Yuichiro Tada, Hideaki Hirai, Daisuke Kawakita, Satoshi Kano, Kiyoaki Tsukahara, Akira Shimizu, Soichiro Takase, Yorihisa Imanishi, Hiroyuki Ozawa et al. · 2017 · Oncotarget
Chemoprevention by Probiotics During 1,2-Dimethylhydrazine-Induced Colon Carcinogenesis in Rats
Sohini Walia, Rozy Kamal, Devinder Kumar Dhawan, Shamsher S. Kanwar · 2018 · Digestive Diseases and Sciences
Differential Expression Profile of NLRs and AIM2 in Glioma and Implications for NLRP12 in Glioblastoma
Nidhi Sharma, Shivanjali Saxena, Ishan Agrawal, Shalini Singh, Varsha Srinivasan, S. Arvind, Sridhar Epari, Sushmita Paul, Sushmita Jha · 2019 · Scientific Reports
A potent CBP/p300-Snail interaction inhibitor suppresses tumor growth and metastasis in wild-type p53-expressing cancer
Hongmei Li, Yan-Ran Bi, Li Yang, Rong Fu, Wen-Cong Lv, Nan Jiang, Ying Xu, Bo‐Xue Ren, Yadong Chen, Hui Xie et al. · 2020 · Science Advances
Significance and limitations of the use of next-generation sequencing technologies for detecting mutational signatures
Ammal Abbasi, Ludmil B. Alexandrov · 2021 · DNA repair
The Effects of Stiffness, Fluid Viscosity, and Geometry of Microenvironment in Homeostasis, Aging, and Diseases: A Brief Review
Seungman Park, Wei‐Hung Jung, Matthew Pittman, Junjie Chen, Yun Chen · 2020 · Journal of Biomechanical Engineering
Spatial transcriptomics analysis of esophageal squamous precancerous lesions and their progression to esophageal cancer
Xuejiao Liu, Simin Zhao, Keke Wang, Liting Zhou, Ming Zuo Jiang, Yunfeng Gao, Ran Yang, Shiwen Yan, Wen Zhang, Bingbing Lu et al. · 2023 · Nature Communications
Therapeutic targeting of HES1 transcriptional programs in T-ALL
Stephanie A. Schnell, Alberto Ambesi‐Impiombato, Marta Sánchez-Martín, Laura Belver, Luyao Xu, Yue Qin, Ryoichiro Kageyama, Adolfo A. Ferrando · 2015 · Blood
Mutagenesis and carcinogenesis induced by dibenzo[a,l]pyrene in the mouse oral cavity: a potential new model for oral cancer
Joseph B. Guttenplan, Wieslawa Kosinska, Zhong‐Lin Zhao, Kun‐Ming Chen, Cesar A. Aliaga, Joseph DelTondo, Timothy K. Cooper, Yuan‐Wan Sun, Shang‐Min Zhang, Kun Jiang et al. · 2011 · International Journal of Cancer
Redox Control and Interplay Between p53 Isoforms: Roles in the Regulation of Basal p53 Levels, Cell Fate, and Senescence
Hind Hafsi, Pierre L. Hainaut · 2011 · Antioxidants and Redox Signaling
Myc Induces miRNA-Mediated Apoptosis in Response to HDAC Inhibition in Hematologic Malignancies
Clare M. Adams, Scott W. Hiebert, Christine M. Eischen · 2015 · Cancer Research
Li–Fraumeni Syndrome Disease Model: A Platform to Develop Precision Cancer Therapy Targeting Oncogenic p53
Ruoji Zhou, An Xu, Julian A. Gingold, Louise C. Strong, Ruiying Zhao, Dung‐Fang Lee · 2017 · Trends in Pharmacological Sciences
Basal p53 expression is indispensable for mesenchymal stem cell integrity
Siddaraju V. Boregowda, Veena Krishnappa, Jacqueline Strivelli, Christopher L. Haga, Cori N. Booker, Donald G. Phinney · 2018 · Cell Death and Differentiation
Loss of p53 suppresses replication-stress-induced DNA breakage in G1/S checkpoint deficient cells
Bente Benedict, Tanja van Harn, Marleen Dekker, Simone Hermsen, Aslι Küçükosmanoğlu, Wietske Pieters, Elly Delzenne‐Goette, Josephine C. Dorsman, Eva Petermann, Floris Foijer et al. · 2018 · eLife
MutatedTP53is a marker of increasedVEGFexpression: analysis of 7,525 pan-cancer tissues
Alex M. Li, Amélie Boichard, Razelle Kurzrock · 2019 · Cancer Biology & Therapy
Novel electrochemical biosensor based on functional composite nanofibers for sensitive detection of p53 tumor suppressor gene
Xiaoying Wang, Xiaoning Wang, Xiaoning Wang, Fentian Chen, Kehui Zhu, Qian Xu, Meng Xiong Tang · 2012 · Analytica Chimica Acta
Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia
Maribel Forero‐Castro, Cristina Robledo, Rocío Benito, Irene Bodega‐Mayor, Inmaculada Rapado, María Hernández‐Sánchez, María Abáigar, Jesús María Hernández-Sánchez, Miguel Quijada‐Álamo, José María Sánchez‐Pina et al. · 2017 · British Journal of Cancer
TP53 mutations and SNPs as prognostic and predictive factors in patients with breast cancer (Review)
Joanna Huszno, Ewa Anna Grzybowska · 2018 · Oncology Letters
Applications of Recombinant Adenovirus-p53 Gene Therapy for Cancers in the Clinic in China
Yu Xia, Xiuqin Li, Wei Sun · 2020 · Current Gene Therapy
TP53 mutations in head and neck cancer
Cherie‐Ann O. Nathan, Alok R. Khandelwal, Gregory T. Wolf, Juan Pablo Rodrigo, Antti A. Mäkitie, Nabil F. Saba, Arlene A. Forastiere, Carol Rossier Bradford, Alfio Ferlito · 2022 · Molecular Carcinogenesis
Highly sulfated chondroitin sulfates, a novel class of prognostic biomarkers in ovarian cancer tissue
Myrtille J.E. Vallen, Leon F.A.G. Massuger, Gerdy B. ten Dam, Johan Bulten, Toin H. Van Kuppevelt · 2012 · Gynecologic Oncology
Negative regulation of the p300-p53 interplay by DDX24
Ding-Ding Shi, C. Dai, J. Qin, W. Gu · 2015 · Oncogene
A Comparative Analysis of Genetic and Epigenetic Events of Breast and Ovarian Cancer Related to Tumorigenesis
Mckenna M. Longacre, Nicole Snyder, Genevieve Housman, Meghan Leary, KAROLINA LAPINSKA, Sarah Heerboth, Amber R. Willbanks, Sibaji Sarkar · 2016 · International Journal of Molecular Sciences
TP53INP1 Downregulation Activates a p73-Dependent DUSP10/ERK Signaling Pathway to Promote Metastasis of Hepatocellular Carcinoma
Kai Yu Ng, Lok-Hei Chan, Stella Chai, Man Tong, Xin‐Yuan Guan, Nikki Pui Yue Lee, Yunfei Yuan, Dan Xie, Terence K. Lee, Nelson Dusetti et al. · 2017 · Cancer Research
PI3K Inhibitors Curtail MYC-Dependent Mutant p53 Gain-of-Function in Head and Neck Squamous Cell Carcinoma
Federica Ganci, Claudio Pulito, Sara Valsoni, Andrea Sacconi, Chiara Turco, Mahrou Vahabi, Valentina Manciocco, Emilia Maria Cristina Mazza, Jalna Meens, Christina Karamboulas et al. · 2020 · Clinical Cancer Research
Understanding next generation sequencing in oncology: A guide for oncologists
Sing Yu Moorcraft, David González de Castro, Brian A. Walker · 2015 · Critical Reviews in Oncology/Hematology
Cancer cells escape p53’s tumor suppression through ablation of ZDHHC1-mediated p53 palmitoylation
Jun Tang, Weiyan Peng, Yixiao Feng, Xin Le, Kang Wang, Qin Xiang, Lili Li, Yan Wang, Can Xu, Junhao Mu et al. · 2021 · Oncogene
p53 triggers mitochondrial apoptosis following DNA damage-dependent replication stress by the hepatotoxin methyleugenol
Max J. Carlsson, Anastasia Sophie Vollmer, Philipp Demuth, Daniel Heylmann, Diana Reich, Caroline Quarz, Birgit Rasenberger, Teodora Nikolova, Thomas G. Hofmann, Markus Christmann et al. · 2022 · Cell Death and Disease
Heme oxygenase-1 has antitumoral effects in colorectal cancer: Involvement of p53
Nancy C. Andrés, María Eugenia Fermento, Norberto Ariel Gandini, Alejandro López Romero, Alejandro Ferro, María Lucila González Donna, Alejandro C. Curino, María M. Facchinetti · 2014 · Experimental and Molecular Pathology
MicroRNAs Involvement in Radioresistance of Head and Neck Cancer
Parwez Ahmad, Jiří Šáňa, M Slavík, Pavel Šlampa, Pavel Smilek, Ondřej Slabý · 2017 · Disease Markers
Genomic Analysis Revealed New Oncogenic Signatures in TP53-Mutant Hepatocellular Carcinoma
Venkatesh Kancherla, Samir Abdullazade, Matthias Sebastian Matter, Manuela Lanzafame, Luca Quagliata, Guglielmo Roma, Yujin Hoshida, Luigi Terracciano, Charlotte K.Y. Ng, Salvatore Piscuoglio · 2018 · Frontiers in Genetics
The Role of the p53 Protein in Stem-Cell Biology and Epigenetic Regulation
Arnold J. Levine, Anna M. Puzio‐Kuter, Chang S. Chan, Pierre L. Hainaut · 2016 · Cold Spring Harbor Perspectives in Medicine
Anti‐leukaemic effects induced by APR‐246 are dependent on induction of oxidative stress and the NFE2L2/HMOX1 axis that can be targeted by PI3K and mTOR inhibitors in acute myeloid leukaemia cells
Ali, Dina, Mohammad, Dara K., Mujahed, Huthayfa, Jonson‐Videsäter, Kerstin, Nore, Beston, Paul, Christer, Lehmann, Sören · 2016 · British Journal of Haematology
Hepatoid adenocarcinoma—Clinicopathological features and molecular characteristics
Ming Li, Yanxia Mei, Jihang Wen, Yu-Rong Jiao, Qiang-Rong Pan, Xiang-Xing Kong, Jun Li · 2023 · Cancer Letters
Gain‐of‐function mutant p53 but not p53 deletion promotes head and neck cancer progression in response to oncogenic K‐ras
Sergio Acı́n, Zhongyou Li, Olga Mejia, Dennis R. Roop, Adel K. El‐Naggar, Carlos Caulı́n · 2011 · The Journal of Pathology
From mutational inactivation to aberrant gain‐of‐function: Unraveling the structural basis of mutant p53 oncogenic transition
Fisayo Andrew Olotu, Mahmoud E. S. Soliman · 2017 · Journal of Cellular Biochemistry
HPV – A different view on Head and Neck Cancer
C. Wittekindt, S. Wagner, S. J. Sharma, N. Würdemann, Jennifer Knuth, Henrike Reder, J. Klussmann · 2018 · Laryngo-Rhino-Otologie
Relationship between p53 status and the bioeffect of ionizing radiation (Review)
Xiaohan Kong, Dehai Yu, Zhaoyi Wang, Sijie Li · 2021 · Oncology Letters
TP53 in Acute Myeloid Leukemia: Molecular Aspects and Patterns of Mutation
Binsah George, Hagop M. Kantarjian, Natalia Baran, Joseph D. Krocker, Adan A. Rios · 2021 · International Journal of Molecular Sciences
Inflammation mediates the effect of discrimination, religiosity, and friendship network on expression of the Tp53 cancer suppressor gene
Ronald L. Simons, Man‐Kit Lei, Sierra Elizabeth Carter, Steven R. H. Beach, Frederick X. Gibbons, Meg Gerrard, Robert A. Philibert · 2019 · SSM - Population Health
MDM2, MDMX, and p73 regulate cell-cycle progression in the absence of wild-type p53
Alyssa M. Klein, Lynn Biderman, David Tong, Bita Alaghebandan, Sakina A. Plumber, Helen S. Mueller, Anne E. van Vlimmeren, Chen Katz, Carol L. Prives · 2021 · Proceedings of the National Academy of Sciences
An Introduction to Fundamentals of Cancer Biology
S. Sriharikrishnaa, Padmanaban S. Suresh, Shama Prasada Kabekkodu · 2023 · Biological and medical physics, biomedical engineering
Exploring the Genetic Orchestra of Cancer: The Interplay Between Oncogenes and Tumor-Suppressor Genes
S. P. Singh, Rakesh Bhaskar, Shampa Ghosh, Bhuvaneshwar Yarlagadda, Dr. Krishna Kumar Singh, Prashant Verma, Sonali Sengupta, Mitko I. Mladenov, Nikola Hadzi‐Petrushev, Radoslav Stojchevski et al. · 2025 · Cancers
Emerging and Evolving Ovarian Cancer Animal Models
Alexander S. Bobbs, Jennifer M. Cole, Karen D. Cowden Dahl · 2015 · Cancer Growth and Metastasis
Acute Myeloid Leukemia: from Mutation Profiling to Treatment Decisions
Courtney Denton Dinardo, Curtis Andrew Lachowiez · 2019 · Current Hematologic Malignancy Reports
Germline TP53 pathogenic variants and breast cancer: A narrative review
Eva Blondeaux, Luca Arecco, Kevin Punie, Rossella Graffeo, Angela Toss, Carmine De Angelis, Lucia Trevisan, Giulia Buzzatti, Sabine C. Linn, Peter Christian Dubsky et al. · 2023 · Cancer Treatment Reviews
Exploring the mechanism of aloe-emodin in the treatment of liver cancer through network pharmacology and cell experiments
Mingyang Zhu, Qingmin He, Yanan Wang, Liying Duan, Kang Rong, Yingying Wu, Ye Ding, Yang Mi, Xiaoyang Ge, Xiaocui Yang et al. · 2023 · Frontiers in Pharmacology
Targeting p53 misfolding conundrum by stabilizing agents and their analogs in breast cancer therapy: a comprehensive computational analysis
Burhan Ul Haq, Hina Qayoom, Shazia Sofi, Nusrat Jan, Aisha Shabir, Irshad Ahmad, Fuzail Ahmad, Abdullah Almilaibary, Manzoor Ahmad Mir · 2024 · Frontiers in Pharmacology
Evaluating DAPK as a therapeutic target
Yide Huang, Ling Chen, Libin Guo, Ted R. Hupp, Yao Lin · 2013 · APOPTOSIS
microRNA-214 enhances the invasion ability of breast cancer cells by targeting p53
Fang Wang, Pengwei Lv, Xinwei Liu, Mingzhi Zhu, Xinguang Qiu · 2015 · International Journal of Molecular Medicine
The impact of p53 on DNA damage and metabolic activation of the environmental carcinogen benzo[a]pyrene: effects in Trp53(+/+), Trp53(+/–) and Trp53(−/−) mice
Annette M. Krais, Ewoud N. Speksnijder, Joost P.M. Melis, Radek Indra, Michaela Moserová, Roger Godschalk, Frederik‐Jan van Schooten, Albrecht Seidel, Klaus Kopka, Heinz H. Schmeiser et al. · 2015 · Archives of Toxicology
Genomic landscape of small cell carcinoma of the breast contrasted to small cell carcinoma of the lung
Brennan McCullar, Manjari K Pandey, George Yaghmour, Felicia Hare, Kruti Patel, Matthew K. Stein, Rebecca A. Feldman, Jason Claud Chandler, Michael Gary Martin · 2016 · Breast Cancer Research and Treatment
The dominant-negative interplay between p53, p63 and p73: A family affair
Olivier Billant, Alice Léon, Solenn Le Guellec, Gaëlle Friocourt, Marc Blondel, Cécile Voisset · 2016 · Oncotarget
p53 gain‐of‐function mutations increase Cdc7‐dependent replication initiation
Arindam Datta, Dishari Ghatak, Sumit Das, Taraswi Banerjee, Anindita Paul, Ramesh Butti, Mahadeo Gorain, Sangeeta Ghuwalewala, Anirban Roychowdhury, Sk. Kayum Alam et al. · 2017 · EMBO Reports
Zinc and Autophagy in Age-Related Macular Degeneration
J. Błasiak, E. Pawłowska, J. Chojnacki, J. Szczepanska, C. Chojnacki, K. Kaarniranta · 2020 · International Journal of Molecular Sciences
Therapeutic Targets and Emerging Treatments in Advanced Chondrosarcoma
Shinji Miwa, Norio Yamamoto, Katsuhiro Hayashi, Akihiko Takeuchi, Kentaro Igarashi, Hiroyuki Tsuchiya · 2022 · International Journal of Molecular Sciences
Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia
Bahaj, Waled, Kewan, Tariq, Gurnari, Carmelo, Durmaz, Arda, Ponvilawan, Ben, Pandit, Ishani, Kubota, Yasuo, Ogbue, Olisaemeka D., Zawit, Misam, Madanat, Yazan et al. · 2023 · Journal of Hematology & Oncology
Accurate detection of circulating tumor DNA using nanopore consensus sequencing
Alessio Marcozzi, Myrthe Jager, Martin Elferink, Roy Straver, Joost H. van Ginkel, Boris Peltenburg, Li‐Ting Chen, Ivo Renkens, Joyce van Kuik, Chris H.J. Terhaard et al. · 2021 · npj Genomic Medicine
TP53 Mutation in Acute Myeloid Leukemia: An Old Foe Revisited
Shin, Dong-Yeop · 2023 · Cancers
From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies
Ehsan Gharib, Gilles A. Robichaud · 2024 · International Journal of Molecular Sciences
Association between Smoking and p53 Mutation in Lung Cancer: A Meta-analysis
Xiaofang Liu, X.J. Lin, C.P. Wang, K.K. Yan, L Zhao, W. X. AN, Xiaofang Liu · 2013 · Clinical Oncology
P53 deregulation in Epstein-Barr virus-associated gastric cancer
Joana Ribeiro, Mariana Malta, Ana Galaghar, FERNANDA ATILA BARBOSA NUNES DA SILVA, Luís Pedro Afonso, Rui Medeiros, Hugo Manuel Lopes de Sousa · 2017 · Cancer Letters
RETRACTED ARTICLE: Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II
Yujing Li, Yunhua Liu, Hanchen Xu, Guanglong Jiang, Kevin Van der Jeught, Yuanzhang Fang, Zhuolong Zhou, Lu Zhang, Michael Frieden, Lifei Wang et al. · 2018 · Nature Communications · Retracted
Mutational profile of endometrial hyperplasia and risk of progression to endometrioid adenocarcinoma
Mariano Russo, Jordan M. Newell, Laura Budurlean, Kenneth R. Houser, Kathryn E. Sheldon, Joshua P. Kesterson, Rébécca Phaëton, Carrie Hossler, Jennifer Rosenberg, David J. DeGraff et al. · 2020 · Cancer